UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000007094 |
|---|---|
| Receipt number | R000008326 |
| Scientific Title | Efficacy of glucose infusion for the inhibition of breakdown of fat tissue and muscle protein under anesthesia |
| Date of disclosure of the study information | 2012/02/01 |
| Last modified on | 2015/01/18 14:47:05 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Efficacy of glucose infusion for the inhibition of breakdown of fat tissue and muscle protein under anesthesia
Acronym
Efficacy of glucose infusion for the inhibition of breakdown of fat tissue and muscle protein under anesthesia
Scientific Title
Efficacy of glucose infusion for the inhibition of breakdown of fat tissue and muscle protein under anesthesia
Scientific Title:Acronym
Efficacy of glucose infusion for the inhibition of breakdown of fat tissue and muscle protein under anesthesia
Region
| Japan |
Condition
Condition
Surgical disease
Classification by specialty
| Anesthesiology | Operative medicine |
Classification by malignancy
Malignancy
Genomic information
NO
Objectives
Narrative objectives1
The efficacy of glucose infusion for the inhibition of breakdown of fat tissue and muscle protein under anesthesia
Basic objectives2
Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Plasma concentrations of acetoacetic acid and 3-hydroxybutyrate acid and urine 3-methylhistidine/plasma creatinine
Key secondary outcomes
Base
Study type
Interventional
Study design
Basic design
Parallel
Randomization
Randomized
Randomization unit
Blinding
Single blind -participants are blinded
Control
Placebo
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
2
Purpose of intervention
Treatment
Type of intervention
| Medicine |
Interventions/Control_1
Glucose was administered at the rate of 2mg/kg/min.
Interventions/Control_2
Glucose was not administered.
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
Patients with ASA physical status 1 or 2
Key exclusion criteria
Patients with endocrine disease or disorder of metabolism, patients with heart failure or renal failure
Target sample size
120
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Michiaki Yamakage |
Organization
Sapporo Medical University
Division name
Department of Anesthesiology
Zip code
Address
South 1 jo, West 16 cho-me, Chu-o-ku, Sapporo, Hokkaido
TEL
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Atsushi Sawada |
Organization
Sapporo Medical University
Division name
Department of Anesthesiology
Zip code
Address
TEL
011-611-2111
Homepage URL
Sponsor or person
Institute
Department of Anesthesiology, Sapporo Medical University School of Medicine
Institute
Department
Personal name
Funding Source
Organization
None
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2012 | Year | 02 | Month | 01 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2012 | Year | 01 | Month | 01 | Day |
Date of IRB
Anticipated trial start date
| 2012 | Year | 02 | Month | 01 | Day |
Last follow-up date
| 2014 | Year | 12 | Month | 31 | Day |
Date of closure to data entry
| 2014 | Year | 12 | Month | 31 | Day |
Date trial data considered complete
| 2014 | Year | 12 | Month | 31 | Day |
Date analysis concluded
| 2014 | Year | 12 | Month | 31 | Day |
Other
Other related information
Management information
Registered date
| 2012 | Year | 01 | Month | 18 | Day |
Last modified on
| 2015 | Year | 01 | Month | 18 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000008326
